Cocrystal Pharma (COCP) Buildings (2011 - 2012)
Cocrystal Pharma (COCP) posted Buildings of $1.7 million for Q4 2012, up 4.25% sequentially from $1.6 million in Q4 2011, and up 4.25% YoY from $1.6 million in Q1 2012.
Cocrystal Pharma (COCP) Buildings (2011 - 2012) Analysis & Trends
Cocrystal Pharma has reported Buildings for 2 years, with the latest figure at $1.7 million in Q4 2012.
- Quarterly Buildings rose 4.25% year-over-year to $1.7 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $1.7 million (up 4.25% YoY) and the FY2012 annual result came in at $1.7 million, up 4.25% from the prior year.
- Buildings rose to $1.7 million in Q4 2012 per COCP's latest filing, from $1.6 million in the prior quarter.
- Over five years, Buildings peaked at $1.7 million in Q4 2012 and troughed at $1.6 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 1.68 Mn |
| Dec 31, 2011 | 1.61 Mn |